Midazolam: Supply issue
The supplier, Baxter has advised that its brand of Midazolam (Midazolam-Claris) 1mg per ml, 5mg injection will be out of stock as of 28 February 2021.
The out of stock is caused by the current stock expiring at the end of February and Baxter’s replacement brand Midazolam-Baxter not yet being available.
To ensure continuity of supply, an alternative brand of Midazolam supplied by Mylan will be listed from 1 February 2021. Note: This product is currently listed in Section H of the schedule but will be available in Section B from 1 February 2021.
Details of the alternative product are as follows:
- Chemical and presentation: Midazolam inj 1 mg per ml, 5 ml ampoule
- Brand: Mylan Midazolam
- Pack Size: 10
- Subsidy and price (ex-man., ex. GST): $2.98
- Pharmacode: 2474468
RxOne users: the new listings and changes will be automatically updated by RxOne. If for some unforeseen circumstance it does not happen, please refer to the e-Noticeboard on the RxOne Home Screen for instructions.
TONIQ users: the new listings and changes will automatically be updated in Toniq medicine databases from the effective date.
Please note that Ministry of Health Sector Operations Group will be able to process claims for February 2021 dispensing of the above listing.
Who to contact
If you have any questions about changing brands, talk with your doctor, nurse, or pharmacist.
If you have questions about funding for Midazolam, contact PHARMAC:
- email: firstname.lastname@example.org
- phone: 0800 660 050